NSRX

Conviction 57HealthcareScan · Mon, Aug 10, 2026

Shooting star

NSRX$3.31-4.20%

ResistanceSupportVol 14Insider buy

Vol MA14 25.47K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Nasus Pharma LtdDrug Manufacturers - Generalwww.nasuspharma.com ↗

Price3.31

Change-4.20%

Gap-6.22%

Rel volume9.52×

Avg volume20.01K

Avg $ vol65.31K

SMA 203.16

SMA 503.17

SMA 2004.31

Price vs 50+4.40%

Price vs 200-23.13%

MA stackmixed

50/200 cross—

Supertrendup · 2.91

RSI (14)54

MACD hist0.03

MACD crossbull · 8d

Stoch %K / %D60 / 71

ADX (14)20

+DI / −DI17 / 8

RSI divergence—

MACD divergence—

ATR %+8.04%

ADR %7.25%

52w high9.15

52w low0.0000

From 52w high-63.83%

Above 52w low—

New 52w highNo

SqueezeOn · 8d

Bollinger width20.01%

%B0.74

Donchian pos60.25%

Donchian high3.60

Donchian low2.87

AVWAP (52w high)3.61

vs AVWAP high-8.40%

AVWAP (52w low)3.44

vs AVWAP low-3.79%

OBV trendFlat

Chaikin MF (20)0.20

Today vs 20d9.52×

Avg vol (14d)25.47K

Avg vol (20d)20.01K

Avg $ vol (20d)65.31K

Market cap29.84M

RS 3m (vs SPY)-3.78%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank32.9

1 week+3.76%

1 month+12.97%

3 months+5.08%

6 months-39.15%

1 year—

YTD-56.16%

P/E—

P/B10.78

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current2.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value28.6M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - General

ExchangeNYSE

Shares out11.71M

Employees7

ListedWed, Aug 13, 2025

Free float6.44M

Float %55.0%

Short interest170.67K

Days to cover11.8d

Short volume33.2%

Squeeze score45 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank32.9 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Congress activity

Disclosed STOCK Act trades in NSRX

All disclosures →

No recent disclosed trades by Congress in NSRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NSRX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Teleman Dan Benjamin Chief Executive Officer · Ordinary Shares · 2026-06-17	Buy	6.55K	$20K	2026-06-17	2026-06-22
Teleman Dan Benjamin Chief Executive Officer · Ordinary Shares · 2026-04-22	Buy	2.9K	$11K	2026-04-22	2026-04-22

SEC filings

EDGAR filings in NSRX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.